Otrivin Paediatric Nasal Drops

• Otrivin Paediatric Nasal Drops is used in the treatment of nasal congestion
• It treats congestion associated with allergies, hay fever, sinus irritation, and the common cold

• Otrivin Paediatric 0.05% w/v Nasal Drops for Fast Relief from Blocked Nose does not pose serious side effects and is well-tolerated by children. In case the side effects do occur, they’re likely to subside once the body adapts to the medicine. Consult your child’s doctor if these side effects persist or bother your child. The most common side effects include- Common side effects of Otrivin Dry nose Nausea Headache Burning sensation Nasal irritation

If you experience any persistent or severe side effects, consult your doctor immediately.

• How can I give Otrivin Paediatric 0.05% w/v Nasal Drops for Fast Relief from Blocked Nose to my child? Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Tilt your head as far back as possible and hold the dropper close to the nose without touching it. Gently squeeze the dropper and place the medicine in the nose. Bend your head forward for a few minutes.

• How Otrivin Nasal Drops works Otrivin Paediatric 0.05% w/v Nasal Drops for Fast Relief from Blocked Nose is a nasal decongestant. It helps in opening up the nasal passages by reducing excessive nasal secretions and also reducing the swelling in the blood vessels in the inner surface of the nose. This provides temporary relief from congestion or stuffiness in the nose.

• 
  Kidney:

  No interaction found/established

• 
  Liver:

  No interaction found/established

• 
  Pregnancy:

  Otrivin Paediatric Nasal Drops may be unsafe to use during pregnancy.Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• 
  Breastfeeding:

  Otrivin Paediatric Nasal Drops is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.